 | • レポートコード：MRC2-11QY08588 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は市販薬（OTC）のグローバル市場について調査・分析したレポートです。種類別（風邪・インフルエンザ製品、鎮痛剤、皮膚科製品、胃腸製品、ビタミン、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別市販薬（OTC）の競争状況、市場シェア ・世界の市販薬（OTC）市場：種類別市場規模 2015年-2020年（風邪・インフルエンザ製品、鎮痛剤、皮膚科製品、胃腸製品、ビタミン、その他） ・世界の市販薬（OTC）市場：種類別市場規模予測 2021年-2026年（風邪・インフルエンザ製品、鎮痛剤、皮膚科製品、胃腸製品、ビタミン、その他） ・世界の市販薬（OTC）市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界の市販薬（OTC）市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米の市販薬（OTC）市場分析：米国、カナダ ・ヨーロッパの市販薬（OTC）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの市販薬（OTC）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の市販薬（OTC）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの市販薬（OTC）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer、Boehringer Ingelheim、GSK、Novartis、Pfizer、PGT healthcare、Sanofi、Teva Pharmaceuticals、Takeda、Cipla、Sun Pharmaceutical Industries、Glenmark、Innovus Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Over-The-Counter (OTC) Drugs Market
The global Over-The-Counter (OTC) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Over-The-Counter (OTC) Drugs Scope and Market Size
Over-The-Counter (OTC) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Over-The-Counter (OTC) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Over-The-Counter (OTC) Drugs market is segmented into
Cold and Flu Products
Analgesics
Dermatological Products
Gastrointestinal Products
Vitamin
Other
Segment by Application, the Over-The-Counter (OTC) Drugs market is segmented into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Regional and Country-level Analysis
The Over-The-Counter (OTC) Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Over-The-Counter (OTC) Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Over-The-Counter (OTC) Drugs Market Share Analysis
Over-The-Counter (OTC) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Over-The-Counter (OTC) Drugs business, the date to enter into the Over-The-Counter (OTC) Drugs market, Over-The-Counter (OTC) Drugs product introduction, recent developments, etc.
The major vendors covered:
Bayer
Boehringer Ingelheim
GSK
Novartis
Pfizer
PGT healthcare
Sanofi
Teva Pharmaceuticals
Takeda
Cipla
Sun Pharmaceutical Industries
Glenmark
Innovus Pharmaceuticals
1 Study Coverage
1.1 Over-The-Counter (OTC) Drugs Product Introduction
1.2 Market Segments
1.3 Key Over-The-Counter (OTC) Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Over-The-Counter (OTC) Drugs Market Size Growth Rate by Type
1.4.2 Cold and Flu Products
1.4.3 Analgesics
1.4.4 Dermatological Products
1.4.5 Gastrointestinal Products
1.4.6 Vitamin
1.4.7 Other
1.5 Market by Application
1.5.1 Global Over-The-Counter (OTC) Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Over-The-Counter (OTC) Drugs Market Size, Estimates and Forecasts
2.1.1 Global Over-The-Counter (OTC) Drugs Revenue 2015-2026
2.1.2 Global Over-The-Counter (OTC) Drugs Sales 2015-2026
2.2 Global Over-The-Counter (OTC) Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Over-The-Counter (OTC) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Over-The-Counter (OTC) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Over-The-Counter (OTC) Drugs Competitor Landscape by Players
3.1 Over-The-Counter (OTC) Drugs Sales by Manufacturers
3.1.1 Over-The-Counter (OTC) Drugs Sales by Manufacturers (2015-2020)
3.1.2 Over-The-Counter (OTC) Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Over-The-Counter (OTC) Drugs Revenue by Manufacturers
3.2.1 Over-The-Counter (OTC) Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Over-The-Counter (OTC) Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Over-The-Counter (OTC) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Over-The-Counter (OTC) Drugs Revenue in 2019
3.2.5 Global Over-The-Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Over-The-Counter (OTC) Drugs Price by Manufacturers
3.4 Over-The-Counter (OTC) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Over-The-Counter (OTC) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Over-The-Counter (OTC) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Over-The-Counter (OTC) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Over-The-Counter (OTC) Drugs Market Size by Type (2015-2020)
4.1.1 Global Over-The-Counter (OTC) Drugs Sales by Type (2015-2020)
4.1.2 Global Over-The-Counter (OTC) Drugs Revenue by Type (2015-2020)
4.1.3 Over-The-Counter (OTC) Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Over-The-Counter (OTC) Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Over-The-Counter (OTC) Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Over-The-Counter (OTC) Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Over-The-Counter (OTC) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Over-The-Counter (OTC) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Over-The-Counter (OTC) Drugs Market Size by Application (2015-2020)
5.1.1 Global Over-The-Counter (OTC) Drugs Sales by Application (2015-2020)
5.1.2 Global Over-The-Counter (OTC) Drugs Revenue by Application (2015-2020)
5.1.3 Over-The-Counter (OTC) Drugs Price by Application (2015-2020)
5.2 Over-The-Counter (OTC) Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Over-The-Counter (OTC) Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Over-The-Counter (OTC) Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Over-The-Counter (OTC) Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Over-The-Counter (OTC) Drugs by Country
6.1.1 North America Over-The-Counter (OTC) Drugs Sales by Country
6.1.2 North America Over-The-Counter (OTC) Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Over-The-Counter (OTC) Drugs Market Facts & Figures by Type
6.3 North America Over-The-Counter (OTC) Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Over-The-Counter (OTC) Drugs by Country
7.1.1 Europe Over-The-Counter (OTC) Drugs Sales by Country
7.1.2 Europe Over-The-Counter (OTC) Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Over-The-Counter (OTC) Drugs Market Facts & Figures by Type
7.3 Europe Over-The-Counter (OTC) Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Over-The-Counter (OTC) Drugs by Region
8.1.1 Asia Pacific Over-The-Counter (OTC) Drugs Sales by Region
8.1.2 Asia Pacific Over-The-Counter (OTC) Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Over-The-Counter (OTC) Drugs Market Facts & Figures by Type
8.3 Asia Pacific Over-The-Counter (OTC) Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Over-The-Counter (OTC) Drugs by Country
9.1.1 Latin America Over-The-Counter (OTC) Drugs Sales by Country
9.1.2 Latin America Over-The-Counter (OTC) Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Over-The-Counter (OTC) Drugs Market Facts & Figures by Type
9.3 Central & South America Over-The-Counter (OTC) Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Over-The-Counter (OTC) Drugs by Country
10.1.1 Middle East and Africa Over-The-Counter (OTC) Drugs Sales by Country
10.1.2 Middle East and Africa Over-The-Counter (OTC) Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Over-The-Counter (OTC) Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Over-The-Counter (OTC) Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description and Business Overview
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Over-The-Counter (OTC) Drugs Products Offered
11.1.5 Bayer Related Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Corporation Information
11.2.2 Boehringer Ingelheim Description and Business Overview
11.2.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Products Offered
11.2.5 Boehringer Ingelheim Related Developments
11.3 GSK
11.3.1 GSK Corporation Information
11.3.2 GSK Description and Business Overview
11.3.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GSK Over-The-Counter (OTC) Drugs Products Offered
11.3.5 GSK Related Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Description and Business Overview
11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis Over-The-Counter (OTC) Drugs Products Offered
11.4.5 Novartis Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Over-The-Counter (OTC) Drugs Products Offered
11.5.5 Pfizer Related Developments
11.6 PGT healthcare
11.6.1 PGT healthcare Corporation Information
11.6.2 PGT healthcare Description and Business Overview
11.6.3 PGT healthcare Sales, Revenue and Gross Margin (2015-2020)
11.6.4 PGT healthcare Over-The-Counter (OTC) Drugs Products Offered
11.6.5 PGT healthcare Related Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Description and Business Overview
11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sanofi Over-The-Counter (OTC) Drugs Products Offered
11.7.5 Sanofi Related Developments
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Corporation Information
11.8.2 Teva Pharmaceuticals Description and Business Overview
11.8.3 Teva Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Products Offered
11.8.5 Teva Pharmaceuticals Related Developments
11.9 Takeda
11.9.1 Takeda Corporation Information
11.9.2 Takeda Description and Business Overview
11.9.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Takeda Over-The-Counter (OTC) Drugs Products Offered
11.9.5 Takeda Related Developments
11.10 Cipla
11.10.1 Cipla Corporation Information
11.10.2 Cipla Description and Business Overview
11.10.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Cipla Over-The-Counter (OTC) Drugs Products Offered
11.10.5 Cipla Related Developments
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description and Business Overview
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Over-The-Counter (OTC) Drugs Products Offered
11.1.5 Bayer Related Developments
11.12 Glenmark
11.12.1 Glenmark Corporation Information
11.12.2 Glenmark Description and Business Overview
11.12.3 Glenmark Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Glenmark Products Offered
11.12.5 Glenmark Related Developments
11.13 Innovus Pharmaceuticals
11.13.1 Innovus Pharmaceuticals Corporation Information
11.13.2 Innovus Pharmaceuticals Description and Business Overview
11.13.3 Innovus Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Innovus Pharmaceuticals Products Offered
11.13.5 Innovus Pharmaceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Over-The-Counter (OTC) Drugs Market Estimates and Projections by Region
12.1.1 Global Over-The-Counter (OTC) Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Over-The-Counter (OTC) Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Over-The-Counter (OTC) Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Over-The-Counter (OTC) Drugs Sales Forecast (2021-2026)
12.2.2 North America: Over-The-Counter (OTC) Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Over-The-Counter (OTC) Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Over-The-Counter (OTC) Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Over-The-Counter (OTC) Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Over-The-Counter (OTC) Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Over-The-Counter (OTC) Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Over-The-Counter (OTC) Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Over-The-Counter (OTC) Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Over-The-Counter (OTC) Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Over-The-Counter (OTC) Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Over-The-Counter (OTC) Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Over-The-Counter (OTC) Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Over-The-Counter (OTC) Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Over-The-Counter (OTC) Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Over-The-Counter (OTC) Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Over-The-Counter (OTC) Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Over-The-Counter (OTC) Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Over-The-Counter (OTC) Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Over-The-Counter (OTC) Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Over-The-Counter (OTC) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Over-The-Counter (OTC) Drugs Market Segments
Table 2. Ranking of Global Top Over-The-Counter (OTC) Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Over-The-Counter (OTC) Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Cold and Flu Products
Table 5. Major Manufacturers of Analgesics
Table 6. Major Manufacturers of Dermatological Products
Table 7. Major Manufacturers of Gastrointestinal Products
Table 8. Major Manufacturers of Vitamin
Table 9. Major Manufacturers of Other
Table 10. Global Over-The-Counter (OTC) Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 11. Global Over-The-Counter (OTC) Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 12. Global Over-The-Counter (OTC) Drugs Sales by Regions 2015-2020 (K Units)
Table 13. Global Over-The-Counter (OTC) Drugs Sales Market Share by Regions (2015-2020)
Table 14. Global Over-The-Counter (OTC) Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Over-The-Counter (OTC) Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 16. Global Over-The-Counter (OTC) Drugs Sales Share by Manufacturers (2015-2020)
Table 17. Global Over-The-Counter (OTC) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Over-The-Counter (OTC) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Over-The-Counter (OTC) Drugs as of 2019)
Table 19. Over-The-Counter (OTC) Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Over-The-Counter (OTC) Drugs Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Over-The-Counter (OTC) Drugs Price (2015-2020) (USD/Unit)
Table 22. Over-The-Counter (OTC) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Over-The-Counter (OTC) Drugs Product Type
Table 24. Date of International Manufacturers Enter into Over-The-Counter (OTC) Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Over-The-Counter (OTC) Drugs Sales by Type (2015-2020) (K Units)
Table 27. Global Over-The-Counter (OTC) Drugs Sales Share by Type (2015-2020)
Table 28. Global Over-The-Counter (OTC) Drugs Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Over-The-Counter (OTC) Drugs Revenue Share by Type (2015-2020)
Table 30. Over-The-Counter (OTC) Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 31. Global Over-The-Counter (OTC) Drugs Sales by Application (2015-2020) (K Units)
Table 32. Global Over-The-Counter (OTC) Drugs Sales Share by Application (2015-2020)
Table 33. North America Over-The-Counter (OTC) Drugs Sales by Country (2015-2020) (K Units)
Table 34. North America Over-The-Counter (OTC) Drugs Sales Market Share by Country (2015-2020)
Table 35. North America Over-The-Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Over-The-Counter (OTC) Drugs Revenue Market Share by Country (2015-2020)
Table 37. North America Over-The-Counter (OTC) Drugs Sales by Type (2015-2020) (K Units)
Table 38. North America Over-The-Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Table 39. North America Over-The-Counter (OTC) Drugs Sales by Application (2015-2020) (K Units)
Table 40. North America Over-The-Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Table 41. Europe Over-The-Counter (OTC) Drugs Sales by Country (2015-2020) (K Units)
Table 42. Europe Over-The-Counter (OTC) Drugs Sales Market Share by Country (2015-2020)
Table 43. Europe Over-The-Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Over-The-Counter (OTC) Drugs Revenue Market Share by Country (2015-2020)
Table 45. Europe Over-The-Counter (OTC) Drugs Sales by Type (2015-2020) (K Units)
Table 46. Europe Over-The-Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Table 47. Europe Over-The-Counter (OTC) Drugs Sales by Application (2015-2020) (K Units)
Table 48. Europe Over-The-Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Over-The-Counter (OTC) Drugs Sales by Region (2015-2020) (K Units)
Table 50. Asia Pacific Over-The-Counter (OTC) Drugs Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Over-The-Counter (OTC) Drugs Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Over-The-Counter (OTC) Drugs Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Over-The-Counter (OTC) Drugs Sales by Type (2015-2020) (K Units)
Table 54. Asia Pacific Over-The-Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Over-The-Counter (OTC) Drugs Sales by Application (2015-2020) (K Units)
Table 56. Asia Pacific Over-The-Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Table 57. Latin America Over-The-Counter (OTC) Drugs Sales by Country (2015-2020) (K Units)
Table 58. Latin America Over-The-Counter (OTC) Drugs Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Over-The-Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Over-The-Counter (OTC) Drugs Revenue Market Share by Country (2015-2020)
Table 61. Latin America Over-The-Counter (OTC) Drugs Sales by Type (2015-2020) (K Units)
Table 62. Latin America Over-The-Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Table 63. Latin America Over-The-Counter (OTC) Drugs Sales by Application (2015-2020) (K Units)
Table 64. Latin America Over-The-Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Over-The-Counter (OTC) Drugs Sales by Country (2015-2020) (K Units)
Table 66. Middle East and Africa Over-The-Counter (OTC) Drugs Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Over-The-Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Over-The-Counter (OTC) Drugs Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Over-The-Counter (OTC) Drugs Sales by Type (2015-2020) (K Units)
Table 70. Middle East and Africa Over-The-Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Over-The-Counter (OTC) Drugs Sales by Application (2015-2020) (K Units)
Table 72. Middle East and Africa Over-The-Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Table 73. Bayer Corporation Information
Table 74. Bayer Description and Major Businesses
Table 75. Bayer Over-The-Counter (OTC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Bayer Product
Table 77. Bayer Recent Development
Table 78. Boehringer Ingelheim Corporation Information
Table 79. Boehringer Ingelheim Description and Major Businesses
Table 80. Boehringer Ingelheim Over-The-Counter (OTC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Boehringer Ingelheim Product
Table 82. Boehringer Ingelheim Recent Development
Table 83. GSK Corporation Information
Table 84. GSK Description and Major Businesses
Table 85. GSK Over-The-Counter (OTC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. GSK Product
Table 87. GSK Recent Development
Table 88. Novartis Corporation Information
Table 89. Novartis Description and Major Businesses
Table 90. Novartis Over-The-Counter (OTC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Novartis Product
Table 92. Novartis Recent Development
Table 93. Pfizer Corporation Information
Table 94. Pfizer Description and Major Businesses
Table 95. Pfizer Over-The-Counter (OTC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Pfizer Product
Table 97. Pfizer Recent Development
Table 98. PGT healthcare Corporation Information
Table 99. PGT healthcare Description and Major Businesses
Table 100. PGT healthcare Over-The-Counter (OTC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. PGT healthcare Product
Table 102. PGT healthcare Recent Development
Table 103. Sanofi Corporation Information
Table 104. Sanofi Description and Major Businesses
Table 105. Sanofi Over-The-Counter (OTC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Sanofi Product
Table 107. Sanofi Recent Development
Table 108. Teva Pharmaceuticals Corporation Information
Table 109. Teva Pharmaceuticals Description and Major Businesses
Table 110. Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Teva Pharmaceuticals Product
Table 112. Teva Pharmaceuticals Recent Development
Table 113. Takeda Corporation Information
Table 114. Takeda Description and Major Businesses
Table 115. Takeda Over-The-Counter (OTC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Takeda Product
Table 117. Takeda Recent Development
Table 118. Cipla Corporation Information
Table 119. Cipla Description and Major Businesses
Table 120. Cipla Over-The-Counter (OTC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Cipla Product
Table 122. Cipla Recent Development
Table 123. Sun Pharmaceutical Industries Corporation Information
Table 124. Sun Pharmaceutical Industries Description and Major Businesses
Table 125. Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. Sun Pharmaceutical Industries Product
Table 127. Sun Pharmaceutical Industries Recent Development
Table 128. Glenmark Corporation Information
Table 129. Glenmark Description and Major Businesses
Table 130. Glenmark Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 131. Glenmark Product
Table 132. Glenmark Recent Development
Table 133. Innovus Pharmaceuticals Corporation Information
Table 134. Innovus Pharmaceuticals Description and Major Businesses
Table 135. Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 136. Innovus Pharmaceuticals Product
Table 137. Innovus Pharmaceuticals Recent Development
Table 138. Global Over-The-Counter (OTC) Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 139. Global Over-The-Counter (OTC) Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 140. Global Over-The-Counter (OTC) Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 141. Global Over-The-Counter (OTC) Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 142. North America: Over-The-Counter (OTC) Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 143. North America: Over-The-Counter (OTC) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 144. Europe: Over-The-Counter (OTC) Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 145. Europe: Over-The-Counter (OTC) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Asia Pacific: Over-The-Counter (OTC) Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 147. Asia Pacific: Over-The-Counter (OTC) Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 148. Latin America: Over-The-Counter (OTC) Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 149. Latin America: Over-The-Counter (OTC) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 150. Middle East and Africa: Over-The-Counter (OTC) Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 151. Middle East and Africa: Over-The-Counter (OTC) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 153. Key Challenges
Table 154. Market Risks
Table 155. Main Points Interviewed from Key Over-The-Counter (OTC) Drugs Players
Table 156. Over-The-Counter (OTC) Drugs Customers List
Table 157. Over-The-Counter (OTC) Drugs Distributors List
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Over-The-Counter (OTC) Drugs Product Picture
Figure 2. Global Over-The-Counter (OTC) Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Cold and Flu Products Product Picture
Figure 4. Analgesics Product Picture
Figure 5. Dermatological Products Product Picture
Figure 6. Gastrointestinal Products Product Picture
Figure 7. Vitamin Product Picture
Figure 8. Other Product Picture
Figure 9. Global Over-The-Counter (OTC) Drugs Sales Market Share by Application in 2020 & 2026
Figure 10. Hospital Pharmacy
Figure 11. Retail Pharmacy
Figure 12. Online Pharmacy
Figure 13. Over-The-Counter (OTC) Drugs Report Years Considered
Figure 14. Global Over-The-Counter (OTC) Drugs Market Size 2015-2026 (US$ Million)
Figure 15. Global Over-The-Counter (OTC) Drugs Sales 2015-2026 (K Units)
Figure 16. Global Over-The-Counter (OTC) Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Over-The-Counter (OTC) Drugs Sales Market Share by Region (2015-2020)
Figure 18. Global Over-The-Counter (OTC) Drugs Sales Market Share by Region in 2019
Figure 19. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Region (2015-2020)
Figure 20. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Region in 2019
Figure 21. Global Over-The-Counter (OTC) Drugs Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Over-The-Counter (OTC) Drugs Revenue in 2019
Figure 23. Over-The-Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Over-The-Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Figure 25. Global Over-The-Counter (OTC) Drugs Sales Market Share by Type in 2019
Figure 26. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Type (2015-2020)
Figure 27. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Type in 2019
Figure 28. Global Over-The-Counter (OTC) Drugs Market Share by Price Range (2015-2020)
Figure 29. Global Over-The-Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Figure 30. Global Over-The-Counter (OTC) Drugs Sales Market Share by Application in 2019
Figure 31. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Application (2015-2020)
Figure 32. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Application in 2019
Figure 33. North America Over-The-Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 34. North America Over-The-Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Over-The-Counter (OTC) Drugs Sales Market Share by Country in 2019
Figure 36. North America Over-The-Counter (OTC) Drugs Revenue Market Share by Country in 2019
Figure 37. U.S. Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. U.S. Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 40. Canada Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Over-The-Counter (OTC) Drugs Market Share by Type in 2019
Figure 42. North America Over-The-Counter (OTC) Drugs Market Share by Application in 2019
Figure 43. Europe Over-The-Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 44. Europe Over-The-Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Over-The-Counter (OTC) Drugs Sales Market Share by Country in 2019
Figure 46. Europe Over-The-Counter (OTC) Drugs Revenue Market Share by Country in 2019
Figure 47. Germany Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. Germany Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. France Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. U.K. Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Italy Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 56. Russia Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Over-The-Counter (OTC) Drugs Market Share by Type in 2019
Figure 58. Europe Over-The-Counter (OTC) Drugs Market Share by Application in 2019
Figure 59. Asia Pacific Over-The-Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific Over-The-Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Over-The-Counter (OTC) Drugs Sales Market Share by Region in 2019
Figure 62. Asia Pacific Over-The-Counter (OTC) Drugs Revenue Market Share by Region in 2019
Figure 63. China Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. China Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. India Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Australia Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Taiwan Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Indonesia Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Thailand Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Malaysia Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Philippines Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 84. Vietnam Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Over-The-Counter (OTC) Drugs Market Share by Type in 2019
Figure 86. Asia Pacific Over-The-Counter (OTC) Drugs Market Share by Application in 2019
Figure 87. Latin America Over-The-Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 88. Latin America Over-The-Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Over-The-Counter (OTC) Drugs Sales Market Share by Country in 2019
Figure 90. Latin America Over-The-Counter (OTC) Drugs Revenue Market Share by Country in 2019
Figure 91. Mexico Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Mexico Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 94. Brazil Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 96. Argentina Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Over-The-Counter (OTC) Drugs Market Share by Type in 2019
Figure 98. Latin America Over-The-Counter (OTC) Drugs Market Share by Application in 2019
Figure 99. Middle East and Africa Over-The-Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 100. Middle East and Africa Over-The-Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Over-The-Counter (OTC) Drugs Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Over-The-Counter (OTC) Drugs Revenue Market Share by Country in 2019
Figure 103. Turkey Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. Turkey Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 106. Saudi Arabia Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 108. U.A.E Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Over-The-Counter (OTC) Drugs Market Share by Type in 2019
Figure 110. Middle East and Africa Over-The-Counter (OTC) Drugs Market Share by Application in 2019
Figure 111. North America Over-The-Counter (OTC) Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. North America Over-The-Counter (OTC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Over-The-Counter (OTC) Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Europe Over-The-Counter (OTC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Over-The-Counter (OTC) Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Asia Pacific Over-The-Counter (OTC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Over-The-Counter (OTC) Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Latin America Over-The-Counter (OTC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Over-The-Counter (OTC) Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Middle East and Africa Over-The-Counter (OTC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
OTC薬の世界市場（～2026年） OTC drugs are medicines that can be bought without a prescription from a doctor. The lenient regulatory framework and the availability of several distribution channels to be some of the major factors that will have a positive impact on the growth of this market in the coming years. Market Analysis a…- 市販用診断製品の世界市場（～2026年） Market Analysis and Insights: Global Over-the-Counter Diagnostic Products Market The global Over-the-Counter Diagnostic Products market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Over-the-Counter Diagnostic Products Scop…
- カウンターUAVの世界市場（～2026年） Counter-drone technology, also known as counter-UAS, C-UAS, or counter-UAV technology, refers to systems that are used to detect and/or intercept unmanned aircraft. As concerns grow around the potential security threats drones may pose to both civilian and military entities, a new market for counter…
- キャッシュカウンターの世界市場（～2026年） Cash counters are widely used by the BFSI sector to count the cash deposited in the bank by account holders or for making any kind of transactions. The machines are primarily used in places where huge money transactions are involved daily. ATM machines also have inbuilt cash counter systems to deter…
- 処方用皮膚科薬の世界市場（～2026年） Market Analysis and Insights: Global Prescription Dermatological Drugs Market The global Prescription Dermatological Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prescription Dermatological Drugs Scope and Mar…